Direct dependence studies in rats with agents selective for different types of opioid receptor

A. Cowan, X. Z. Zhu, H. I. Mosberg, J. R. Omnaas, Frank Porreca

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

The objective of this study was to describe, quantitate and compare naloxone-induced abstinence syndromes in rats infused centrally (Sylvian aqueduct) with agonists that are currently the most selective for mu ([D-Ala2, MePhe4, Gly-ol5]enkephalin), delta ([D-Pen2, D-Pen5]enkephalin) and kappa (3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexyl]benzeneacetamide) (U-50,488H) opioid receptors, respectively. Morphine, ethylketazocine and dynorphin A served as reference compounds. After 70 hr of infusion from s.c. implanted osmotic minipumps, three levels of abstinence were associated with the injection of naloxone (3 mg/kg s.c.): 1) negligible syndromes (scores of <21) were obtained in rats on water or the kappa-directed ligands, U-50,488H and dynorphin A; 2) a low-to-moderate abstinence score (37-38) was recorded with rats receiving [D-Pen2, D-Pen5]enkephalin and ethylketazocine; and 3) a high abstinence score (64-73) was obtained with rats on morphine and DAGO. These results reinforce the concept of developing selective, nonbenzomorphan kappa agonists as clinically useful analgesics and emphasize that, when evaluating new analgesics, high selectivity for delta receptors does not, in itself, guarantee freedom from physical dependence.

Original languageEnglish (US)
Pages (from-to)950-955
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume246
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Opioid Receptors
Ethylketocyclazocine
(trans)-Isomer 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide
D-Penicillamine (2,5)-Enkephalin
Dynorphins
Naloxone
Morphine
Analgesics
Benzeneacetamides
Cerebral Aqueduct
Ala(2)-MePhe(4)-Gly(5)-enkephalin
delta Opioid Receptor
Enkephalins
Ligands
Injections
Water

ASJC Scopus subject areas

  • Pharmacology

Cite this

Direct dependence studies in rats with agents selective for different types of opioid receptor. / Cowan, A.; Zhu, X. Z.; Mosberg, H. I.; Omnaas, J. R.; Porreca, Frank.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 246, No. 3, 1988, p. 950-955.

Research output: Contribution to journalArticle

@article{e6f4c7bb01eb489aa8bbd788c50142ca,
title = "Direct dependence studies in rats with agents selective for different types of opioid receptor",
abstract = "The objective of this study was to describe, quantitate and compare naloxone-induced abstinence syndromes in rats infused centrally (Sylvian aqueduct) with agonists that are currently the most selective for mu ([D-Ala2, MePhe4, Gly-ol5]enkephalin), delta ([D-Pen2, D-Pen5]enkephalin) and kappa (3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexyl]benzeneacetamide) (U-50,488H) opioid receptors, respectively. Morphine, ethylketazocine and dynorphin A served as reference compounds. After 70 hr of infusion from s.c. implanted osmotic minipumps, three levels of abstinence were associated with the injection of naloxone (3 mg/kg s.c.): 1) negligible syndromes (scores of <21) were obtained in rats on water or the kappa-directed ligands, U-50,488H and dynorphin A; 2) a low-to-moderate abstinence score (37-38) was recorded with rats receiving [D-Pen2, D-Pen5]enkephalin and ethylketazocine; and 3) a high abstinence score (64-73) was obtained with rats on morphine and DAGO. These results reinforce the concept of developing selective, nonbenzomorphan kappa agonists as clinically useful analgesics and emphasize that, when evaluating new analgesics, high selectivity for delta receptors does not, in itself, guarantee freedom from physical dependence.",
author = "A. Cowan and Zhu, {X. Z.} and Mosberg, {H. I.} and Omnaas, {J. R.} and Frank Porreca",
year = "1988",
language = "English (US)",
volume = "246",
pages = "950--955",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Direct dependence studies in rats with agents selective for different types of opioid receptor

AU - Cowan, A.

AU - Zhu, X. Z.

AU - Mosberg, H. I.

AU - Omnaas, J. R.

AU - Porreca, Frank

PY - 1988

Y1 - 1988

N2 - The objective of this study was to describe, quantitate and compare naloxone-induced abstinence syndromes in rats infused centrally (Sylvian aqueduct) with agonists that are currently the most selective for mu ([D-Ala2, MePhe4, Gly-ol5]enkephalin), delta ([D-Pen2, D-Pen5]enkephalin) and kappa (3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexyl]benzeneacetamide) (U-50,488H) opioid receptors, respectively. Morphine, ethylketazocine and dynorphin A served as reference compounds. After 70 hr of infusion from s.c. implanted osmotic minipumps, three levels of abstinence were associated with the injection of naloxone (3 mg/kg s.c.): 1) negligible syndromes (scores of <21) were obtained in rats on water or the kappa-directed ligands, U-50,488H and dynorphin A; 2) a low-to-moderate abstinence score (37-38) was recorded with rats receiving [D-Pen2, D-Pen5]enkephalin and ethylketazocine; and 3) a high abstinence score (64-73) was obtained with rats on morphine and DAGO. These results reinforce the concept of developing selective, nonbenzomorphan kappa agonists as clinically useful analgesics and emphasize that, when evaluating new analgesics, high selectivity for delta receptors does not, in itself, guarantee freedom from physical dependence.

AB - The objective of this study was to describe, quantitate and compare naloxone-induced abstinence syndromes in rats infused centrally (Sylvian aqueduct) with agonists that are currently the most selective for mu ([D-Ala2, MePhe4, Gly-ol5]enkephalin), delta ([D-Pen2, D-Pen5]enkephalin) and kappa (3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexyl]benzeneacetamide) (U-50,488H) opioid receptors, respectively. Morphine, ethylketazocine and dynorphin A served as reference compounds. After 70 hr of infusion from s.c. implanted osmotic minipumps, three levels of abstinence were associated with the injection of naloxone (3 mg/kg s.c.): 1) negligible syndromes (scores of <21) were obtained in rats on water or the kappa-directed ligands, U-50,488H and dynorphin A; 2) a low-to-moderate abstinence score (37-38) was recorded with rats receiving [D-Pen2, D-Pen5]enkephalin and ethylketazocine; and 3) a high abstinence score (64-73) was obtained with rats on morphine and DAGO. These results reinforce the concept of developing selective, nonbenzomorphan kappa agonists as clinically useful analgesics and emphasize that, when evaluating new analgesics, high selectivity for delta receptors does not, in itself, guarantee freedom from physical dependence.

UR - http://www.scopus.com/inward/record.url?scp=0023715894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023715894&partnerID=8YFLogxK

M3 - Article

C2 - 2901490

AN - SCOPUS:0023715894

VL - 246

SP - 950

EP - 955

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -